MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.

More >

While international attention focuses on Myanmar, a health crisis in the country looms large. An estimated 85,000 people infected with HIV in Myanmar are not receiving lifesaving treatment. 

More >

Dr. Unni Karunakara, international president of MSF, calls on the board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria to organize an emergency donor conference to renew commitment in the wake of the cancellation of the new round of funding applications.

More >

The cancelation of Round 11 of the Global Fund to Fight AIDS, Tuberculosis, and Malaria undermines the significant progress that has been made in the uphill battles against these deadly diseases.

More >

While several countries hardest hit by the AIDS epidemic are improving HIV treatment protocols to reduce deaths and illness, a lack of support from donors prevents many from implementing vital changes.

More >

I am writing on behalf of MSF to express our disappointment that J&J has not yet placed any patent into the Medicines Patent Pool and that it has announced in a recent letter to the Medicines Patent Pool that it is not ready to engage in formal negotiations.

More >

But just as important gains are beginning to show their promise for patients, a stagnation in donor funding, coupled with trade policies that will create serious additional barriers to accessing affordable generic medicines, are dealing HIV/AIDS treatment a double blow.

More >

MSF Teleconference on Innovative Financing Mechanisms for Global Health, conducted September 20, 2010

More >

by Dr. Martin De Smet, Head of MSF's Working Group on Malaria

More >

NY Times Lettter-to-the-Editor on MSF concerns that a provision in proposed U.S. health care legislation will allow pharmaceutical companies to extend monopolies on high-priced, cutting-edge medicines.

More >

Pages